Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2005 Nov;97(11):1489–1495.

The influence of G-CSF addition to antibiotic treatment of experimental sepsis on pulmonary tissue.

Sevim Aydin 1, Rahmet Caylan 1, Kemalettin Aydin 1, Esin Yulug 1, Engin Yenilmez 1, Iftihar Koksal 1
PMCID: PMC2594918  PMID: 16334496

Abstract

AIM: To investigate the effects of G-CSF addition to antibiotic treatment of experimental sepsis on pulmonary lung tissue. MATERIALS AND METHODS: Fifty Sprague-Dawley rats were used. The first four groups received a bolus intraperitoneal injection of Pseudomonas aeruginosa. The first group (Group SAG) received a combined therapy of imipenem and G-CSF, the second group (Group SA) received only imipenem, the third group (Group SG) received only G-CSF, and no antibiotic or G-CSF was given to the fourth group (Group S). The fifth group (Group C) served as the control. Survival rates, peripheral leukocyte counts (PLC) and absolute neutrophil counts (ANC) were obtained, and lung tissues were examined under light microscopy. RESULTS: Survival rates at the 120th hour were 100% in groups SAG, SA and C; 20% in group SG; and 0% in group S. PLC and ANC values reached their highest levels at the 36th hour in the SAG group and at the 60th hour in the SA group. Pulmonary architecture was better preserved in the SAG, SA and SG groups--in that order--than in the S group. CONCLUSION: Particularly in the early phase of infection, the administration of G-CSF in combination with antibiotics would be appropriate for maximizing the effect of antibiotics as soon as possible and for minimizing the damage caused by inflammation.

Full text

PDF
1489

Images in this article

1494Figure 3
on p.1494

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Attalah Habiba L., Azoulay Elie, Yang Kun, Lasclos Christine, Jouault Hélène, Soussy Claude-James, Guillot Thierry, Brochard Laurent, Brun-Buisson Christian, Harf Alain. Granulocyte colony-stimulating factor enhances host defenses against bacterial pneumonia following peritonitis in nonneutropenic rats. Crit Care Med. 2002 Sep;30(9):2107–2114. doi: 10.1097/00003246-200209000-00026. [DOI] [PubMed] [Google Scholar]
  2. Barsig J., Bundschuh D. S., Hartung T., Bauhofer A., Sauer A., Wendel A. Control of fecal peritoneal infection in mice by colony-stimulating factors. J Infect Dis. 1996 Oct;174(4):790–799. doi: 10.1093/infdis/174.4.790. [DOI] [PubMed] [Google Scholar]
  3. Bauhofer A., Witte K., Celik I., Pummer S., Lemmer B., Lorenz W. Sickness behaviour, an animal equivalent to human quality of life, is improved in septic rats by G-CSF and antibiotic prophylaxis. Langenbecks Arch Surg. 2001 Mar;386(2):132–140. doi: 10.1007/s004230100206. [DOI] [PubMed] [Google Scholar]
  4. Bauhofer Artur, Tischer Bjirn, Middeke Martin, Plaul Ulrike, Lorenz Wilfried, Torossian Alexander. The genetic background of hypertensive, septic rats determines outcome improvement with antibiotic and G-CSF prophylaxis. Shock. 2003 Oct;20(4):326–331. doi: 10.1097/01.shk.0000084342.58020.1e. [DOI] [PubMed] [Google Scholar]
  5. Bauhofer Artur, Torossian Alexander, Lorenz Wilfried, Middeke Martin, Plaul Ulrike, Schütz Philipp, Stinner Benno, Hattel Markus, Celik Ilhan. Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regimen: evaluation in rats with polymicrobial peritonitis. World J Surg. 2004 Aug 3;28(8):834–844. doi: 10.1007/s00268-004-7210-1. [DOI] [PubMed] [Google Scholar]
  6. Bone R. C., Balk R. A., Cerra F. B., Dellinger R. P., Fein A. M., Knaus W. A., Schein R. M., Sibbald W. J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 Jun;101(6):1644–1655. doi: 10.1378/chest.101.6.1644. [DOI] [PubMed] [Google Scholar]
  7. Casey L. C., Balk R. A., Bone R. C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993 Oct 15;119(8):771–778. doi: 10.7326/0003-4819-119-8-199310150-00001. [DOI] [PubMed] [Google Scholar]
  8. Cohen A. M., Hines D. K., Korach E. S., Ratzkin B. J. In vivo activation of neutrophil function in hamsters by recombinant human granulocyte colony-stimulating factor. Infect Immun. 1988 Nov;56(11):2861–2865. doi: 10.1128/iai.56.11.2861-2865.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dunne J. R., Dunkin B. J., Nelson S., White J. C. Effects of granulocyte colony stimulating factor in a nonneutropenic rodent model of Escherichia coli peritonitis. J Surg Res. 1996 Mar;61(2):348–354. doi: 10.1006/jsre.1996.0128. [DOI] [PubMed] [Google Scholar]
  10. Görgen I., Hartung T., Leist M., Niehörster M., Tiegs G., Uhlig S., Weitzel F., Wendel A. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol. 1992 Aug 1;149(3):918–924. [PubMed] [Google Scholar]
  11. Hartung T., Döcke W. D., Gantner F., Krieger G., Sauer A., Stevens P., Volk H. D., Wendel A. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood. 1995 May 1;85(9):2482–2489. [PubMed] [Google Scholar]
  12. Karzai W., von Specht B. U., Parent C., Haberstroh J., Wollersen K., Natanson C., Banks S. M., Eichacker P. Q. G-CSF during Escherichia coli versus Staphylococcus aureus pneumonia in rats has fundamentally different and opposite effects. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1377–1382. doi: 10.1164/ajrccm.159.5.9806082. [DOI] [PubMed] [Google Scholar]
  13. Le Tulzo Yves, Pangault Céllne, Gacouin Arnaud, Guilloux Valérie, Tribut Olivier, Amiot Laurence, Tattevin Pierre, Thomas Rémi, Fauchet Renée, Drénou Bernard. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock. 2002 Dec;18(6):487–494. doi: 10.1097/00024382-200212000-00001. [DOI] [PubMed] [Google Scholar]
  14. Liles W. C., Kiener P. A., Ledbetter J. A., Aruffo A., Klebanoff S. J. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med. 1996 Aug 1;184(2):429–440. doi: 10.1084/jem.184.2.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lundblad R., Giercksky K. E. Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats. Crit Care Med. 1995 Aug;23(8):1382–1390. doi: 10.1097/00003246-199508000-00012. [DOI] [PubMed] [Google Scholar]
  16. Lundblad R., Nesland J. M., Giercksky K. E. Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit Care Med. 1996 May;24(5):820–826. doi: 10.1097/00003246-199605000-00016. [DOI] [PubMed] [Google Scholar]
  17. Oz N., Agalar C., Daphan C. E., Agalar F., Turkyilmaz R. Effect of teicoplanin and G-CSF on survival in experimental MRSA pneumonia in neutropenic mice. Int J Surg Investig. 2001;2(5):347–352. [PubMed] [Google Scholar]
  18. Ozdulger Ali, Cinel Ismail, Koksel Oguz, Cinel Leyla, Avlan Dincer, Unlu Ali, Okcu Hulya, Dikmengil Murat, Oral Ugur. The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock. 2003 Apr;19(4):366–372. doi: 10.1097/00024382-200304000-00012. [DOI] [PubMed] [Google Scholar]
  19. Peter F. W., Schuschke D. A., Barker J. H., Fleishcher-Peter B., Pierangeli S., Vogt P. M., Steinau H. U. The effect of severe burn injury on proinflammatory cytokines and leukocyte behavior: its modulation with granulocyte colony-stimulating factor. Burns. 1999 Sep;25(6):477–486. doi: 10.1016/s0305-4179(99)00036-4. [DOI] [PubMed] [Google Scholar]
  20. Quezado Zenaide M. N., Eichacker Peter Q. Prophylactic granulocyte colony-stimulating factor in the critically ill: carefully balancing the benefits and risks. Crit Care Med. 2002 Sep;30(9):2162–2164. doi: 10.1097/00003246-200209000-00045. [DOI] [PubMed] [Google Scholar]
  21. Saba Rabin, Güler Muhsin, Inan Dilara, Oğnç Dilara, Atalay Sakir, Mamikoğlu Latife, Günseren Filiz. The effect of granulocyte colony-stimulating factor in the treatment of Escherichia coli peritonitis with or without ceftriaxone in a nonneutropenic rat model. Surg Today. 2003;33(7):504–508. doi: 10.1007/s10595-002-2539-3. [DOI] [PubMed] [Google Scholar]
  22. Steinberg Jay, Halter Jeffrey, Schiller Henry J., Dasilva Monica, Landas Steve, Gatto Louis A., Maisi Paivi, Sorsa Timo, Rajamaki Minna, Lee Hsi-Ming. Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. J Surg Res. 2003 May 15;111(2):185–195. doi: 10.1016/s0022-4804(03)00089-1. [DOI] [PubMed] [Google Scholar]
  23. Toda H., Murata A., Matsuura N., Uda K., Oka Y., Tanaka N., Mori T. Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model. Stem Cells. 1993 May;11(3):228–234. doi: 10.1002/stem.5530110310. [DOI] [PubMed] [Google Scholar]
  24. Torossian Alexander, Ruehlmann Sebastian, Middeke Martin, Sessler Daniel I., Lorenz Wilfried, Wulf Hinnerk F., Bauhofer Artur. Deleterious effects of mild hypothermia in septic rats are ameliorated by granulocyte colony-stimulating factor. Anesthesiology. 2003 Nov;99(5):1087–1092. doi: 10.1097/00000542-200311000-00014. [DOI] [PubMed] [Google Scholar]
  25. Tsokos M., Fehlauer F., Püschel K. Immunohistochemical expression of E-selectin in sepsis-induced lung injury. Int J Legal Med. 2000;113(6):338–342. doi: 10.1007/s004149900105. [DOI] [PubMed] [Google Scholar]
  26. Villa P., Shaklee C. L., Meazza C., Agnello D., Ghezzi P., Senaldi G. Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis. J Infect Dis. 1998 Aug;178(2):471–477. doi: 10.1086/515643. [DOI] [PubMed] [Google Scholar]
  27. Yasuda H., Ajiki Y., Shimozato T., Kasahara M., Kawada H., Iwata M., Shimizu K. Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect Immun. 1990 Aug;58(8):2502–2509. doi: 10.1128/iai.58.8.2502-2509.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zhang P., Bagby G. J., Stoltz D. A., Spitzer J. A., Summer W. R., Nelson S. Modulation of the lung host response by granulocyte colony-stimulating factor in rats challenged with intrapulmonary endotoxin. Shock. 1997 Mar;7(3):193–199. doi: 10.1097/00024382-199703000-00007. [DOI] [PubMed] [Google Scholar]
  29. Zhang P., Bagby G. J., Stoltz D. A., Summer W. R., Nelson S. Enhancement of peritoneal leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis. Crit Care Med. 1998 Feb;26(2):315–321. doi: 10.1097/00003246-199802000-00035. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES